ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,072.15
1.07%
Dow Jones
38,282.69
1.00%
US Dollar vs MXN
16.9636
0.12%
Brent Oil
83.74
0.24%
Bitcoin
59,302.32
1.83%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ABVC BioPharma Inc (ABVC)

  7. ABVC BioPharma Inc (ABVC) Noticias

ABVC ABVC BioPharma Inc

1.159
0.029 (2.57%)
Última actualización: 13:53:34
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ABVC BioPharma Inc ABVC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.029 2.57% 1.159 13:53:34
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.12 1.10 1.16 1.13
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202408:25GLOBEAiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
17/4/202408:00GLOBEABVC BioPharma Executes a Global Licensing Definitive..
10/4/202407:30GLOBEABVC BioPharma Executes a Global Licensing Term Sheet for..
26/3/202407:30GLOBEABVC BioPharma Entered into a Global Licensing Deal of..
21/3/202407:30GLOBEAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
19/3/202407:30GLOBEABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
14/3/202408:30GLOBEABVC BioPharma Reports Annual 2023 Financials and Provides..
29/2/202415:32EDGAR2Form 8-K/A - Current report: [Amend]
29/2/202415:31EDGAR2Form 8-K/A - Current report: [Amend]
27/2/202407:30GLOBEABVC's New Horizon for Oncology and Hematology Aims at..
16/2/202416:04EDGAR2Form S-1/A - General form for registration of securities..
15/2/202407:30GLOBEABVC BioPharma Executes a Definitive Agreement to Receive..
13/2/202418:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202407:30GLOBEABVC BioPharma Receives Australian Patent, Valid Until 2040,..
09/2/202416:04EDGAR2Form S-1/A - General form for registration of securities..
08/2/202408:30EDGAR2Form 8-K - Current report
08/2/202408:17GLOBEABVC Acquires $2.96 Million Worth of Land in Asia with..
17/1/202416:01EDGAR2Form 8-K/A - Current report: [Amend]
17/1/202416:00EDGAR2Form 8-K - Current report
17/1/202415:30EDGAR2Form 8-K - Current report
12/1/202416:01EDGAR2Form S-1 - General form for registration of securities under..
03/1/202406:24GLOBEABVC BioPharma and its Subsidiary Receive $460M From AiBtl..
07/12/202307:30GLOBEABVC BioPharma Announces Completion of Subject Treatment for..
05/12/202307:30GLOBEABVC BioPharma Shares Insights from Dr. Scott Irwin of..
21/11/202307:30GLOBEABVC BioPharma Receives U.S. Patent for ADHD Treatment, a..
20/11/202307:30EDGAR2Form 8-K - Current report
17/11/202316:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/11/202316:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
16/11/202309:05GLOBEABVC BioPharma Enters Definitive Agreement with Licensing..
16/11/202308:20EDGAR2Form 8-K - Current report
15/11/202308:00GLOBEABVC BioPharma Reports Third Quarter 2023 Financial and..
15/11/202307:41EDGAR2Form 8-K - Current report
15/11/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202307:30GLOBEABVC BioPharma Entered Into a Term Sheet to License Global..
17/10/202307:30GLOBEABVC BioPharma Announces Completion of Subject Recruitment..
09/10/202307:30GLOBEABVC BioPharma Receives Taiwanese Patent for Its Treatment..
13/9/202308:01EDGAR2Form 8-K - Current report
06/9/202307:30EDGAR2Form 8-K/A - Current report: [Amend]
31/8/202307:30EDGAR2Form 8-K - Current report
23/8/202307:30GLOBEABVC BioPharma Provides Updates on ADHD Phase IIb Clinical..
17/8/202316:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/8/202316:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/8/202308:19GLOBEABVC Executes Cooperation Agreement for Strategic..
17/8/202307:33EDGAR2Form 8-K - Current report
14/8/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:30GLOBEABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid..
09/8/202316:00EDGAR2Form 8-K/A - Current report: [Amend]
07/8/202315:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/8/202307:30GLOBEABVC Corporate Update and CEO's Letter to Shareholders
07/8/202307:00EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
ABVC
ABVC BioPharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados